Publikationen von H. Daub
Alle Typen
Zeitschriftenartikel (29)
21.
Zeitschriftenartikel
6 (3), S. 537 - 547 (2007)
Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Molecular & Cellular Proteomics 22.
Zeitschriftenartikel
5 (10 Suppl. Suppl. S), S. S168 - S168 (2006)
Quantitative analysis of receptor tyrosine kinase signaling exploited by Listeria monocytogenes. Molecular & Cellular Proteomics 23.
Zeitschriftenartikel
1 (1), S. 67 - 95 (2006)
Signal transduction therapy with rationally designed kinase inhibitors. Current Signal Transduction Therapy 24.
Zeitschriftenartikel
1754 (1-2), S. 183 - 190 (2005)
Characterisation of kinase-selective inhibitors by chemical proteomics. Biochimica et Biophysica Acta-Proteins and Proteomics 25.
Zeitschriftenartikel
65 (15), S. 6919 - 6926 (2005)
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling. Cancer Research 26.
Zeitschriftenartikel
3 (12), S. 1001 - 1010 (2004)
Strategies to overcome resistance to targeted protein kinase inhibitors. Nature Reviews Drug Discovery 27.
Zeitschriftenartikel
11 (5), S. 691 - 701 (2004)
Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors. Chemistry & Biology 28.
Zeitschriftenartikel
278 (17), S. 15435 - 15440 (2003)
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors. Journal of Biological Chemistry 29.
Zeitschriftenartikel
76 (16), S. 8124 - 8137 (2002)
Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. Journal of Virology Meeting Abstract (1)
30.
Meeting Abstract
120 (21), 786. 54th Annual Meeting and Exposition of the American-Society-of-Hematology
(ASH), Atlanta, GA, 08. Dezember 2012 - 11. Dezember 2012. AMER SOC HEMATOLOGY, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA (2012)
Global Phosphoproteome Analysis of AML Bone Marrow Reveals Predictive Markers for the Treatment with AC220. In BLOOD, Hochschulschrift - Habilitation (1)
31.
Hochschulschrift - Habilitation
Analysis of protein kinases by chemical proteomics. Habilitation, Technische Universität, München (2010)